Diaceutics (LON:DXRX) Hits New 1-Year High – What’s Next?

Diaceutics PLC (LON:DXRX)’s share price hit a new 52-week high during trading on Thursday . The company traded as high as GBX 180 and last traded at GBX 180, with a volume of 246222 shares. The stock had previously closed at GBX 174.

Analyst Ratings Changes

Separately, Shore Capital Group boosted their target price on shares of Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a report on Thursday, January 15th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of GBX 193.33.

Diaceutics Price Performance

The firm has a market cap of £152.33 million, a PE ratio of -100.00 and a beta of 0.94. The company has a quick ratio of 9.92, a current ratio of 3.96 and a debt-to-equity ratio of 3.05. The stock has a 50 day moving average price of GBX 155.28 and a two-hundred day moving average price of GBX 153.75.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.